Global Flu Vaccine Market Analysis and Forecast 2024-2030
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
According to APO Research, The global Flu Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
This report presents an overview of global market for Flu Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Flu Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Flu Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Flu Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Flu Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Flu Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi Pasteur, CSL, GSK, Mylan, Hulan Bio, AstraZeneca and CCBIO, etc.
Flu Vaccine segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flu Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Flu Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Flu Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Chapter 14: The main concluding insights of the report.
According to APO Research, The global Flu Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
This report presents an overview of global market for Flu Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Flu Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Flu Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Flu Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Flu Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Flu Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi Pasteur, CSL, GSK, Mylan, Hulan Bio, AstraZeneca and CCBIO, etc.
Flu Vaccine segment by Company
- Sanofi Pasteur
- CSL
- GSK
- Mylan
- Hulan Bio
- AstraZeneca
- CCBIO
- Trivalent Influenza Vaccine
- Quadrivalent Influenza Vaccine
- For Children (6 months to 3 years)
- For Adults and Children over 3 years
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flu Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Flu Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Flu Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Chapter 14: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Flu Vaccine Market by Type
1.2.1 Global Flu Vaccine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Flu Vaccine Market by Application
1.3.1 Global Flu Vaccine Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 FLU VACCINE MARKET DYNAMICS
2.1 Flu Vaccine Industry Trends
2.2 Flu Vaccine Industry Drivers
2.3 Flu Vaccine Industry Opportunities and Challenges
2.4 Flu Vaccine Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Flu Vaccine Revenue Estimates and Forecasts (2019-2030)
3.2 Global Flu Vaccine Revenue by Region
3.2.1 Global Flu Vaccine Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Flu Vaccine Revenue by Region (2019-2024)
3.2.3 Global Flu Vaccine Revenue by Region (2025-2030)
3.2.4 Global Flu Vaccine Revenue Market Share by Region (2019-2030)
3.3 Global Flu Vaccine Sales Estimates and Forecasts 2019-2030
3.4 Global Flu Vaccine Sales by Region
3.4.1 Global Flu Vaccine Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Flu Vaccine Sales by Region (2019-2024)
3.4.3 Global Flu Vaccine Sales by Region (2025-2030)
3.4.4 Global Flu Vaccine Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Flu Vaccine Revenue by Manufacturers
4.1.1 Global Flu Vaccine Revenue by Manufacturers (2019-2024)
4.1.2 Global Flu Vaccine Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Flu Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Flu Vaccine Sales by Manufacturers
4.2.1 Global Flu Vaccine Sales by Manufacturers (2019-2024)
4.2.2 Global Flu Vaccine Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Flu Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Flu Vaccine Sales Price by Manufacturers (2019-2024)
4.4 Global Flu Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Flu Vaccine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Flu Vaccine Manufacturers, Product Type & Application
4.7 Global Flu Vaccine Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Flu Vaccine Market CR5 and HHI
4.8.2 2023 Flu Vaccine Tier 1, Tier 2, and Tier
5 FLU VACCINE MARKET BY TYPE
5.1 Global Flu Vaccine Revenue by Type
5.1.1 Global Flu Vaccine Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Flu Vaccine Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Flu Vaccine Revenue Market Share by Type (2019-2030)
5.2 Global Flu Vaccine Sales by Type
5.2.1 Global Flu Vaccine Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Flu Vaccine Sales by Type (2019-2030) & (M Doses)
5.2.3 Global Flu Vaccine Sales Market Share by Type (2019-2030)
5.3 Global Flu Vaccine Price by Type
6 FLU VACCINE MARKET BY APPLICATION
6.1 Global Flu Vaccine Revenue by Application
6.1.1 Global Flu Vaccine Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Flu Vaccine Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Flu Vaccine Revenue Market Share by Application (2019-2030)
6.2 Global Flu Vaccine Sales by Application
6.2.1 Global Flu Vaccine Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Flu Vaccine Sales by Application (2019-2030) & (M Doses)
6.2.3 Global Flu Vaccine Sales Market Share by Application (2019-2030)
6.3 Global Flu Vaccine Price by Application
7 COMPANY PROFILES
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Comapny Information
7.1.2 Sanofi Pasteur Business Overview
7.1.3 Sanofi Pasteur Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Sanofi Pasteur Flu Vaccine Product Portfolio
7.1.5 Sanofi Pasteur Recent Developments
7.2 CSL
7.2.1 CSL Comapny Information
7.2.2 CSL Business Overview
7.2.3 CSL Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 CSL Flu Vaccine Product Portfolio
7.2.5 CSL Recent Developments
7.3 GSK
7.3.1 GSK Comapny Information
7.3.2 GSK Business Overview
7.3.3 GSK Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 GSK Flu Vaccine Product Portfolio
7.3.5 GSK Recent Developments
7.4 Mylan
7.4.1 Mylan Comapny Information
7.4.2 Mylan Business Overview
7.4.3 Mylan Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Mylan Flu Vaccine Product Portfolio
7.4.5 Mylan Recent Developments
7.5 Hulan Bio
7.5.1 Hulan Bio Comapny Information
7.5.2 Hulan Bio Business Overview
7.5.3 Hulan Bio Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Hulan Bio Flu Vaccine Product Portfolio
7.5.5 Hulan Bio Recent Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Comapny Information
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 AstraZeneca Flu Vaccine Product Portfolio
7.6.5 AstraZeneca Recent Developments
7.7 CCBIO
7.7.1 CCBIO Comapny Information
7.7.2 CCBIO Business Overview
7.7.3 CCBIO Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 CCBIO Flu Vaccine Product Portfolio
7.7.5 CCBIO Recent Developments
8 NORTH AMERICA
8.1 North America Flu Vaccine Market Size by Type
8.1.1 North America Flu Vaccine Revenue by Type (2019-2030)
8.1.2 North America Flu Vaccine Sales by Type (2019-2030)
8.1.3 North America Flu Vaccine Price by Type (2019-2030)
8.2 North America Flu Vaccine Market Size by Application
8.2.1 North America Flu Vaccine Revenue by Application (2019-2030)
8.2.2 North America Flu Vaccine Sales by Application (2019-2030)
8.2.3 North America Flu Vaccine Price by Application (2019-2030)
8.3 North America Flu Vaccine Market Size by Country
8.3.1 North America Flu Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Flu Vaccine Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Flu Vaccine Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Flu Vaccine Market Size by Type
9.1.1 Europe Flu Vaccine Revenue by Type (2019-2030)
9.1.2 Europe Flu Vaccine Sales by Type (2019-2030)
9.1.3 Europe Flu Vaccine Price by Type (2019-2030)
9.2 Europe Flu Vaccine Market Size by Application
9.2.1 Europe Flu Vaccine Revenue by Application (2019-2030)
9.2.2 Europe Flu Vaccine Sales by Application (2019-2030)
9.2.3 Europe Flu Vaccine Price by Application (2019-2030)
9.3 Europe Flu Vaccine Market Size by Country
9.3.1 Europe Flu Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Flu Vaccine Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Flu Vaccine Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Flu Vaccine Market Size by Type
10.1.1 China Flu Vaccine Revenue by Type (2019-2030)
10.1.2 China Flu Vaccine Sales by Type (2019-2030)
10.1.3 China Flu Vaccine Price by Type (2019-2030)
10.2 China Flu Vaccine Market Size by Application
10.2.1 China Flu Vaccine Revenue by Application (2019-2030)
10.2.2 China Flu Vaccine Sales by Application (2019-2030)
10.2.3 China Flu Vaccine Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Flu Vaccine Market Size by Type
11.1.1 Asia Flu Vaccine Revenue by Type (2019-2030)
11.1.2 Asia Flu Vaccine Sales by Type (2019-2030)
11.1.3 Asia Flu Vaccine Price by Type (2019-2030)
11.2 Asia Flu Vaccine Market Size by Application
11.2.1 Asia Flu Vaccine Revenue by Application (2019-2030)
11.2.2 Asia Flu Vaccine Sales by Application (2019-2030)
11.2.3 Asia Flu Vaccine Price by Application (2019-2030)
11.3 Asia Flu Vaccine Market Size by Country
11.3.1 Asia Flu Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Flu Vaccine Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Flu Vaccine Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Flu Vaccine Market Size by Type
12.1.1 MEALA Flu Vaccine Revenue by Type (2019-2030)
12.1.2 MEALA Flu Vaccine Sales by Type (2019-2030)
12.1.3 MEALA Flu Vaccine Price by Type (2019-2030)
12.2 MEALA Flu Vaccine Market Size by Application
12.2.1 MEALA Flu Vaccine Revenue by Application (2019-2030)
12.2.2 MEALA Flu Vaccine Sales by Application (2019-2030)
12.2.3 MEALA Flu Vaccine Price by Application (2019-2030)
12.3 MEALA Flu Vaccine Market Size by Country
12.3.1 MEALA Flu Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Flu Vaccine Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Flu Vaccine Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Flu Vaccine Value Chain Analysis
13.1.1 Flu Vaccine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Flu Vaccine Production Mode & Process
13.2 Flu Vaccine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Flu Vaccine Distributors
13.2.3 Flu Vaccine Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
1.1 Product Definition
1.2 Flu Vaccine Market by Type
1.2.1 Global Flu Vaccine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Flu Vaccine Market by Application
1.3.1 Global Flu Vaccine Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 FLU VACCINE MARKET DYNAMICS
2.1 Flu Vaccine Industry Trends
2.2 Flu Vaccine Industry Drivers
2.3 Flu Vaccine Industry Opportunities and Challenges
2.4 Flu Vaccine Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Flu Vaccine Revenue Estimates and Forecasts (2019-2030)
3.2 Global Flu Vaccine Revenue by Region
3.2.1 Global Flu Vaccine Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Flu Vaccine Revenue by Region (2019-2024)
3.2.3 Global Flu Vaccine Revenue by Region (2025-2030)
3.2.4 Global Flu Vaccine Revenue Market Share by Region (2019-2030)
3.3 Global Flu Vaccine Sales Estimates and Forecasts 2019-2030
3.4 Global Flu Vaccine Sales by Region
3.4.1 Global Flu Vaccine Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Flu Vaccine Sales by Region (2019-2024)
3.4.3 Global Flu Vaccine Sales by Region (2025-2030)
3.4.4 Global Flu Vaccine Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Flu Vaccine Revenue by Manufacturers
4.1.1 Global Flu Vaccine Revenue by Manufacturers (2019-2024)
4.1.2 Global Flu Vaccine Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Flu Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Flu Vaccine Sales by Manufacturers
4.2.1 Global Flu Vaccine Sales by Manufacturers (2019-2024)
4.2.2 Global Flu Vaccine Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Flu Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Flu Vaccine Sales Price by Manufacturers (2019-2024)
4.4 Global Flu Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Flu Vaccine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Flu Vaccine Manufacturers, Product Type & Application
4.7 Global Flu Vaccine Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Flu Vaccine Market CR5 and HHI
4.8.2 2023 Flu Vaccine Tier 1, Tier 2, and Tier
5 FLU VACCINE MARKET BY TYPE
5.1 Global Flu Vaccine Revenue by Type
5.1.1 Global Flu Vaccine Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Flu Vaccine Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Flu Vaccine Revenue Market Share by Type (2019-2030)
5.2 Global Flu Vaccine Sales by Type
5.2.1 Global Flu Vaccine Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Flu Vaccine Sales by Type (2019-2030) & (M Doses)
5.2.3 Global Flu Vaccine Sales Market Share by Type (2019-2030)
5.3 Global Flu Vaccine Price by Type
6 FLU VACCINE MARKET BY APPLICATION
6.1 Global Flu Vaccine Revenue by Application
6.1.1 Global Flu Vaccine Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Flu Vaccine Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Flu Vaccine Revenue Market Share by Application (2019-2030)
6.2 Global Flu Vaccine Sales by Application
6.2.1 Global Flu Vaccine Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Flu Vaccine Sales by Application (2019-2030) & (M Doses)
6.2.3 Global Flu Vaccine Sales Market Share by Application (2019-2030)
6.3 Global Flu Vaccine Price by Application
7 COMPANY PROFILES
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Comapny Information
7.1.2 Sanofi Pasteur Business Overview
7.1.3 Sanofi Pasteur Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Sanofi Pasteur Flu Vaccine Product Portfolio
7.1.5 Sanofi Pasteur Recent Developments
7.2 CSL
7.2.1 CSL Comapny Information
7.2.2 CSL Business Overview
7.2.3 CSL Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 CSL Flu Vaccine Product Portfolio
7.2.5 CSL Recent Developments
7.3 GSK
7.3.1 GSK Comapny Information
7.3.2 GSK Business Overview
7.3.3 GSK Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 GSK Flu Vaccine Product Portfolio
7.3.5 GSK Recent Developments
7.4 Mylan
7.4.1 Mylan Comapny Information
7.4.2 Mylan Business Overview
7.4.3 Mylan Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Mylan Flu Vaccine Product Portfolio
7.4.5 Mylan Recent Developments
7.5 Hulan Bio
7.5.1 Hulan Bio Comapny Information
7.5.2 Hulan Bio Business Overview
7.5.3 Hulan Bio Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Hulan Bio Flu Vaccine Product Portfolio
7.5.5 Hulan Bio Recent Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Comapny Information
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 AstraZeneca Flu Vaccine Product Portfolio
7.6.5 AstraZeneca Recent Developments
7.7 CCBIO
7.7.1 CCBIO Comapny Information
7.7.2 CCBIO Business Overview
7.7.3 CCBIO Flu Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 CCBIO Flu Vaccine Product Portfolio
7.7.5 CCBIO Recent Developments
8 NORTH AMERICA
8.1 North America Flu Vaccine Market Size by Type
8.1.1 North America Flu Vaccine Revenue by Type (2019-2030)
8.1.2 North America Flu Vaccine Sales by Type (2019-2030)
8.1.3 North America Flu Vaccine Price by Type (2019-2030)
8.2 North America Flu Vaccine Market Size by Application
8.2.1 North America Flu Vaccine Revenue by Application (2019-2030)
8.2.2 North America Flu Vaccine Sales by Application (2019-2030)
8.2.3 North America Flu Vaccine Price by Application (2019-2030)
8.3 North America Flu Vaccine Market Size by Country
8.3.1 North America Flu Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Flu Vaccine Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Flu Vaccine Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Flu Vaccine Market Size by Type
9.1.1 Europe Flu Vaccine Revenue by Type (2019-2030)
9.1.2 Europe Flu Vaccine Sales by Type (2019-2030)
9.1.3 Europe Flu Vaccine Price by Type (2019-2030)
9.2 Europe Flu Vaccine Market Size by Application
9.2.1 Europe Flu Vaccine Revenue by Application (2019-2030)
9.2.2 Europe Flu Vaccine Sales by Application (2019-2030)
9.2.3 Europe Flu Vaccine Price by Application (2019-2030)
9.3 Europe Flu Vaccine Market Size by Country
9.3.1 Europe Flu Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Flu Vaccine Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Flu Vaccine Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Flu Vaccine Market Size by Type
10.1.1 China Flu Vaccine Revenue by Type (2019-2030)
10.1.2 China Flu Vaccine Sales by Type (2019-2030)
10.1.3 China Flu Vaccine Price by Type (2019-2030)
10.2 China Flu Vaccine Market Size by Application
10.2.1 China Flu Vaccine Revenue by Application (2019-2030)
10.2.2 China Flu Vaccine Sales by Application (2019-2030)
10.2.3 China Flu Vaccine Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Flu Vaccine Market Size by Type
11.1.1 Asia Flu Vaccine Revenue by Type (2019-2030)
11.1.2 Asia Flu Vaccine Sales by Type (2019-2030)
11.1.3 Asia Flu Vaccine Price by Type (2019-2030)
11.2 Asia Flu Vaccine Market Size by Application
11.2.1 Asia Flu Vaccine Revenue by Application (2019-2030)
11.2.2 Asia Flu Vaccine Sales by Application (2019-2030)
11.2.3 Asia Flu Vaccine Price by Application (2019-2030)
11.3 Asia Flu Vaccine Market Size by Country
11.3.1 Asia Flu Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Flu Vaccine Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Flu Vaccine Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Flu Vaccine Market Size by Type
12.1.1 MEALA Flu Vaccine Revenue by Type (2019-2030)
12.1.2 MEALA Flu Vaccine Sales by Type (2019-2030)
12.1.3 MEALA Flu Vaccine Price by Type (2019-2030)
12.2 MEALA Flu Vaccine Market Size by Application
12.2.1 MEALA Flu Vaccine Revenue by Application (2019-2030)
12.2.2 MEALA Flu Vaccine Sales by Application (2019-2030)
12.2.3 MEALA Flu Vaccine Price by Application (2019-2030)
12.3 MEALA Flu Vaccine Market Size by Country
12.3.1 MEALA Flu Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Flu Vaccine Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Flu Vaccine Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Flu Vaccine Value Chain Analysis
13.1.1 Flu Vaccine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Flu Vaccine Production Mode & Process
13.2 Flu Vaccine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Flu Vaccine Distributors
13.2.3 Flu Vaccine Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
